Hodgkin’s Lymphoma
Show Only Open Trials
1.
An Open-Label, Dose Escalation, Phase 1 Study of MLN9708, A Second-Generation Proteasome Inhibitor, in Adult Patients with Lymphoma
- Study Status: Open to Enrollment
- Sponsor: Millennium
- Disease Status and/or Stage: Relapsed or Refractory Lymphoma (non-Hodgkin and Hodgkin)
2.
Coping with Lymphoma to Enhance Adjustment and Reduce Stress in Survivors (CLEAR Stress)
- Study Status: Open to Enrollment
- Sponsor: Agency for Healthcare Research and Quality; Weill Cornell Medical College
3.
Pilot study of abbreviated chemotherapy based on early positron emission tomography in Hodgkin lymphoma
- Study Status: Open to Enrollment
- Sponsor: Weill Cornell Medical College
- Disease Status and/or Stage: Untreated Hodgkin Lymphoma
